Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewSmith Asset Management was an independent investment management partnership based in London, founded in 2003 by a group of senior former Merrill Lynch executives. The firm specialized in managing a variety of equity strategies, including long-only and hedge fund products, with a particular focus on European and Japanese markets. At its peak, the firm managed over $1 billion in assets for institutional investors and private clients. In February 2015, NewSmith was acquired by Man Group, a global active investment management firm, to bolster its discretionary investment platform. Following the acquisition, NewSmith's investment teams and assets were integrated into Man Group's GLG division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewSmith Asset Management.